Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bonig

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Leukemia|September 7, 2012
Hematopoietic stem cell mobilization: updated conceptual renditionsH Bonig, T Papayannopoulou
Journal of Translational Medicine|October 21, 2020
Mesenchymal stromal cells for osteonecrosisS Elgaz, H Bonig, P Bader
Vox Sanguinis|April 27, 2011
Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trialS Brauninger, H Bialleck, K Thorausch, et al.
European Cells & Materials|March 7, 2018
The osteo-inductive activity of bone-marrow-derived mononuclear cells resides within the CD14+ population and is independent of the CD34+ populationD Henrich, C Seebach, R Verboket, et al.
Immunological Investigations|January 5, 2002
Co-operation of IL-1 and IL-2 on T-cell activation in mononuclear cell culturesJ Verheyen, H Bonig, U Banning, et al.
Bone Marrow Transplantation|August 5, 2014
Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donationS Bräuninger, K Thorausch, B Luxembourg, et al.
Clinical and Experimental Immunology|April 24, 2013
Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cellsS M Büchner, K Sliva, H Bonig, et al.
Vox Sanguinis|July 26, 2012
Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up studyM M Mueller, H Bialleck, B Bomke, et al.
Journal of Translational Medicine|March 15, 2022
Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donationJ Heyn, S Bräuninger, M Dimova-Dobreva, et al.
Leukemia|September 28, 2013
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than PlerixaforD Karpova, K Dauber, G Spohn, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Leukemia|September 7, 2012
Hematopoietic stem cell mobilization: updated conceptual renditionsH Bonig, T Papayannopoulou
Journal of Translational Medicine|October 21, 2020
Mesenchymal stromal cells for osteonecrosisS Elgaz, H Bonig, P Bader
Vox Sanguinis|April 27, 2011
Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trialS Brauninger, H Bialleck, K Thorausch, et al.
European Cells & Materials|March 7, 2018
The osteo-inductive activity of bone-marrow-derived mononuclear cells resides within the CD14+ population and is independent of the CD34+ populationD Henrich, C Seebach, R Verboket, et al.
Immunological Investigations|January 5, 2002
Co-operation of IL-1 and IL-2 on T-cell activation in mononuclear cell culturesJ Verheyen, H Bonig, U Banning, et al.
Bone Marrow Transplantation|August 5, 2014
Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donationS Bräuninger, K Thorausch, B Luxembourg, et al.
Clinical and Experimental Immunology|April 24, 2013
Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cellsS M Büchner, K Sliva, H Bonig, et al.
Vox Sanguinis|July 26, 2012
Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up studyM M Mueller, H Bialleck, B Bomke, et al.
Journal of Translational Medicine|March 15, 2022
Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donationJ Heyn, S Bräuninger, M Dimova-Dobreva, et al.
Leukemia|September 28, 2013
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than PlerixaforD Karpova, K Dauber, G Spohn, et al.
Pageof 2